Tribute Pharmaceuticals Canada Inc (TBUFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,500 | -11,390 | -4,180 | -5,080 | -4,270 |
| Depreciation Amortization | 2,650 | 1,250 | 520 | 1,390 | 830 |
| Other Working Capital | -2,950 | 0 | -980 | 10 | -670 |
| Other Operating Activity | 6,180 | 6,360 | 2,510 | 1,970 | 770 |
| Operating Cash Flow | $-3,620 | $-3,780 | $-2,130 | $-1,710 | $-3,340 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -10 | -4 | -10 | -6 |
| Net Acquisitions | -8,990 | 0 | 0 | 0 | 0 |
| Other Investing Activity | -4,970 | -11,870 | -66 | -29,510 | -204 |
| Investing Cash Flow | $-13,970 | $-11,880 | $-70 | $-29,520 | $-210 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 24,970 | 26,120 | 2,740 | 32,570 | 27,080 |
| Financing Cash Flow | $24,970 | $26,120 | $2,740 | $32,570 | $27,080 |
| Exchange Rate Effect | 60 | 10,440 | 1,110 | -700 | 300 |
| Beginning Cash Position | 2,680 | 2,850 | 2,830 | 2,540 | 2,580 |
| End Cash Position | 10,120 | 14,310 | 4,480 | 3,170 | 26,410 |
| Net Cash Flow | $7,430 | $11,460 | $1,650 | $620 | $23,820 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,620 | -3,780 | -2,130 | -1,710 | -3,340 |
| Free Cash Flow | -3,620 | -3,780 | -2,130 | -1,710 | -3,340 |